Recall Record

Mountain View, CA, United States

Viewray, Inc. recalls

5 recalls recorded since 2018, most recently on 4 May 2021. None are listed as ongoing. Status and classification are as published by the FDA.

Recalls5
Ongoing (FDA)0
Terminated or completed5
Class I (FDA)0

Terminated Class II Medical devices

Recall started
4 May 2021
Terminated
19 October 2023
Reason
Software anomalies affecting the French, German and Italian versions of treatment delivery system (TDS) software.
Distribution
International distribution only to the countries of France, Germany, Italy, and Switzerland.
Initiated
Voluntary: Firm initiated
Recall number
Z-1836-2021

Terminated Class II Medical devices

Recall started
20 October 2020
Terminated
13 October 2023
Reason
There is a potential that components of the receive coil can reach elevated temperatures which has the potential to cause a burn injury to the patient or user.
Distribution
Worldwide Distribution: US (nationwide) to states of: CA, NY, FL, IL, MI, MO, OR, WI and OUS countries of: France, Germany, Italy, United Kingdom, Taiwan, Netherlands, Israel, and Denmark.
Initiated
Voluntary: Firm initiated
Recall numbers
Z-0481-2021, Z-0482-2021

Terminated Class II Medical devices

Recall started
18 November 2019
Terminated
22 February 2023
Reason
Registering dose and structures in the treatment delivery workflow could result in an alignment discrepancy between the imported previously delivered dose and the displayed patient anatomy and structures. The MRIdian TPDS software shows this misalignment to the user in the predicted dose-volume histogram (DVH). The misalignment impact may not be obvious to the user. During plan re-optimization the previously delivered dose would be incorrectly accounted for by the software. This may result in unexpectedly higher or lower dose than the intended dose calculated for the subsequent treatment plan. When this occurs in the treatment planning workflow, the registration fails to align the dose with the image and the user is unable to proceed.
Distribution
Worldwide distribution. US states of MO, WI, CA, FL, MI, NY, MI, IL, and MA. South Korea, Netherlands, Italy, Japan, Germany, UAE, Turkey, France, Israel, Denmark, Switzerland, and United Kingdom. The distributors are assigned to applicable regions. Firm send the Urgent Device Corrections to
Initiated
Voluntary: Firm initiated
Recall number
Z-1803-2020

Terminated Class II Medical devices

Recall started
18 March 2019
Terminated
16 June 2022
Reason
A discrepancy between optimization and planning forward dose calculation between adaptive optimizations and AQA dose calculations can occur.
Distribution
Distribution was made to FL, IL, MI, MO, NY, and WI. There was no government/military distribution. Foreign distribution was made to Denmark, France, Germany, Netherlands, South Korea, Switzerland, Turkey, UAE,
Initiated
Voluntary: Firm initiated
Recall number
Z-1251-2019

Terminated Class II Medical devices

Recall started
3 March 2019
Terminated
28 April 2021
Reason
Issue with transferring treatment regiment from one system to another. Adequate instructions for transferring treatment plan(s) are not provided within the operator's manual or within the software operating system.
Distribution
US - CA, FL, IL, MI, MO, NY, and WI OUS: Denmark, France, Germany, Italy, Japan, Netherlands, Turkey, South Korea, and UAE
Initiated
Voluntary: Firm initiated
Recall number
Z-0676-2020

A terminated FDA recall means the FDA has determined that all reasonable efforts to remove or correct the product have been made. What statuses mean.